Study of PM54 in Combination With Cytotoxic and Targeted Agents in Adult Participants With Advanced Malignancies
Study of PM54 in Combination With Cytotoxic and Targeted Agents in Adult Participants With Advanced Malignancies
Not yet recruiting · NCT07839819 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of PM54 in Combination With Cytotoxic and Targeted Agents in Adult Participants With Advanced Malignancies | Advanced Solid Tumor | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-24 | NCT07839819 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| PharmaMar | 8 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Antoine Lacassagne | Nice | France | 60 |
| Centre Leon Berard - Lyon | Lyon | France | 1 |
| Helios Klinikum Berlin-Buch | Buckow | Germany | 1 |
| Institut Bergonie | Bordeaux | France | 26 |
| Instituto Portugues De Oncologia Do Porto Francisco Gentil Epe Ipo Porto Ipopfg Clinica De Onco Hematologia | Porto | Portugal | 1 |
| START Lisbon - ULS Santa Maria | Lisbon | Portugal | 1 |
| The University of Texas MD Anderson Cancer Center | Houston | United States | 207 |
| Universitaetsmedizin Mainz | Mainz | Germany | 2 |
| University of Nebraska Medical Center | Omaha | United States | 397 |